Agenda

Due to possible spacing needs, agenda times might shift to accommodate. Please check the website for regular updates.

Displaying agenda in the event’s time zone (CET, GMT +2)

MASTERCLASSES
Wednesday, 29 March, 2023
CONFERENCE DAY 1
Thursday, 30 March, 2023
CONFERENCE DAY 2
Friday, 31 March, 2023

Registration and Networking Breakfast

Synthesizing Primary Research Into Actionable Insights and Presentations

When it comes to gaining valuable insights from primary research, the challenge lies in synthesizing research data and drawing actionable insights to achieve your research objectives.

The Molekule team will highlight the key considerations in designing primary research projects, synthesizing actionable insights from collected data, and articulating key findings into impactful and strategic presentations leading to a shared understanding.

Presented by Molekule Consulting

Coffee Break

Mastering Timelines Assumptions – A Practical Guide on How to Elevate Your Competitors’ Analysis

An interactive session where the Lifescience Dynamics team will share its knowledge and experience in understanding and evaluating EU regulatory timelines.

• An introduction to EU regulatory pathways and differences to US pathways
• How do we benchmark and make assumptions about EU regulatory timelines?
• Case studies: Examples from past EU approvals

Presented by Lifescience Dynamics

Networking Lunch

Developing a Competitive Activity Framework to Enhance Organizational Competitiveness

This workshop session will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS’ proprietary methodologies.

Key to this session will be addressing business needs across the lifecycle, whereby participants will:
· Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
· Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
· Receive hands-on opportunities to apply learnings to a pharma case-study in a learning environment
Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.

Presented by INOVIS

Coffee Break

Building a Winning Strategy: Turning Insights into Actions

Turning insights into actions will help you stay ahead of the competition and increase your competitive readiness.

Strategic workshops are powerful tools for your teams to turn insights into actions and build a winning strategy. Through these workshops, you will get a better understanding of your competitive landscape, evaluate your current strategies, assumptions, and resources, and create new strategies & tactics to help you stay ahead of the competition.

Presented by Atacana Group

Masterclasses Conclude

Good Morning! Registration & Welcome Coffee in Exhibition Hall

Chairpersons’ Opening Remarks

Presented by Novartis and STADA

Keynote: How to Create Highly Engaged Organizations After Pandemic

A talk about the VUCA world we are in and what it means in terms of:

• Leadership
• HR Organization (hybrid working)
• New performance management approach
• New Talent management approach

Presented by Organon

Keynote: Thriving Beyond Uncertainty, Chaos, and Crisis

The world appears to be breaking apart with pandemics, population decline, financial crises, climate impacts, social tensions, and wars.

It is an ongoing rollercoaster that challenges governments, nonprofits, and corporate environments. However, there is always an opportunity to thrive in uncertain times by leveraging key insights into utilizing intelligence about the future to anticipate change, understanding the various types of emergence, and avoiding disruption by imagining and building new global scenarios where humans collaborate with AI to understand emerging issues.

Presented by FFWD

Refresh & Connect in Exhibition Hall

Keynote: Demonstrating the Value of CI: Why and How?

Competitive intelligence is important because it helps businesses understand their competitive environment and the opportunities and challenges it presents.

However, staying on top of competitive intelligence requires an investment which grows over time. Therefore, it is imperative that an organization sees the value of CI. The Molekule team will provide an overview of how to demonstrate the value of CI by empowering your organization with the takeaways and tactics they need to improve decision-making and execution.

Presented by Molekule Consulting

Keynote: Generics & Biosimilars – Important learnings from real world case studies

This session highlights innovative approaches leveraged by generic and biosimilars to speed up market entry. Specifically, this presentation will enable you to:

• Advance your understanding of core regulatory routes, timelines and strategies
• Understand core Gx/biosimilar product development and entry strategies
• Learn from & set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program
The presentation will be supported by thought provoking real-world case studies to stress differences between theory vs actual approaches

Presented by INOVIS

Keynote: Outmanoeuvre Your Competitors: Leveraging Synergy between CI and Simulation (Csw) To Optimise Your Strategy – Preparing for Biosimilar Entry, a Pan European Case Study

Lifescience Dynamics will discuss how competitive intelligence can be used together with competitive simulation workshops to identify market access opportunities and build a successful strategy

• Understand how competitors perceive and prioritize key access challenges and their approaches to address them
• Identify GTM activities and strategies that address healthcare systems’ needs and how they are implemented throughout the development and launch of the product
• Assess how success is measured and benchmark by competitors, payers, patients and prescribers

Presented by Lifescience Dynamics

Networking Luncheon

Strategic CI: Creation and Development

At Servier we have a dedicated Corporate CI department aiming at using CI skills at a macroscopic level i.e. in identifying key environmental swing factors, or risks over the long term (geopolitics turmoil, disruptive ways of working, new healthcare players etc.)

Case studies will be discussed as well as practical implementation of such department, and how it fuels the strategic decision-making at C-suite level or contributes to the dissemination of strategic CI mindset/methodology/tools across the different functions.

Presented by Servier

Hot Topics! Issues and Challenges Facing Global Healthcare in 2023 & CI Solutions to Stay Ahead of Trends

Join us as we unpack some of the most prevalent issues facing healthcare this year.

From the innovators and disruptors, to socio-geo-political aspects, and looking economic uncertainty, we will apply a comprehensive lens to this year’s challenges and potential implications, in order that global CI practitioners remain agile and poised to navigate the dynamics of 2023 and beyond.

Presented by Fletcher

Applications of AI in Clinical Trials and How this will Underpin the Future of Personalised Medicine

Join us to explore how AI in clinical trials paves the way for personalised medicine

Clinical trials have followed the ‘cave-(wo)man’ test since their inception. Patient takes drug and is compared to patient who doesn’t take drug. However, the gains for this process for new medicine development is diminishing. AI is revolutionising supply chains across industries, and clinical trials are no exception. Join us in Rome to hear how AI will enable faster, safer, and significantly less expensive clinical trials. Discover what the future may lie ahead for clinical trials in silico, learn what is an N=1 trial and how this paves the way for the future of personalised medicine.

Presented by Dig Worldwide

Refuel & Rejuvenate in Exhibition Hall

Strategic Insights to Influence Medical and Commercial Planning

From designing your clinical development strategy to optimizing your commercial planning, having the necessary forward-looking insight is key to confident cross-functional decision making.

No longer can competitor, market and stakeholder intelligence be delivered on an ad hoc basis in a format that is difficult to decipher; decision-makers require dynamic, targeted, high-impact insight that provides clarity and empowers them to act in a timely manner.

Presented by Prescient

“Ask the Experts” Interactive ROUNDTABLES

(Explore and capture the power of participants’ insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
ROUNDTABLE 1
CI Organizational Setup- the Pros and Cons of Different Company Approaches

Presented by Novartis

ROUNDTABLE 2
Insights for New Product and Business Development in a Biotech Startup

Presented by Alentis Therapeutics

ROUNDTABLE 3
Can CI Add Value to Customer Experience?

Presented by Chiesi Farmaceutici S.p.A.

ROUNDTABLE 4
The Role and Position of BI within Project Teams – Expectations vs Reality

• How and to which level is BI is involved in project team activities (regular ones and/or strategic ones)

• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)

Presented by SOTIO, a.s.

ROUNDTABLE 5
The Advantages (and Disadvantages) of Social Media Listening for Market Research

Presented by STADA

ROUNDTABLE 6
Career Development

Presented by Bristol Myers Squibb

Integrating Customer Insights with Competitive Intelligence for a Deeper Market Understanding

To really understand the market dynamics well, one needs to understand the perspectives of customers, competitors, and collaborators.

While market research is squarely focused on the “customers” piece of the equation, competitive intelligence provides crucial insight into the way the market shifts as a result of competitor activity. Through this talk, we explain, with the help of some examples, when and how CI can be interwoven into market research to unlock a unique perspective of the market that is not only more comprehensive but also more forward-looking and actionable.

Presented by Lifescience Dynamics

Cocktail Reception and Networking (sponsored by Lifescience Dynamics)

Good Morning! Registration & Welcome Coffee in Exhibition Hall

Chairpersons’ Opening Remarks

Presented by Novartis and STADA

Keynote: Strategic Decision Making: Turning insights into actions

The aim of competitive intelligence is to help Pharma Leaders to develop a winning strategy.

The traditional CI model of gathering intelligence and generating insights is not enough. Developing, launching and growing blockbuster brands require a well defined strategic decision making process.

In this presentation, we will share our proven 3 step process needed to identify your key competitors, assess several credible scenarios, determine risks and opportunities, identify the key success factors, and create an action plan to execute within your winning strategy.

The presentation incorporates learnings from leading the CI functions at Roche and Novartis, supporting the majority of Big Pharma companies CI efforts, the latest management thinking from Harvard Business School, and years of cross-functional experience within Pharma and at Atacana.

We look forward to seeing you there!

Presented by Atacana Group

Keynote: Changing Behavior Is Hard: Avoid the Dashboard Pitfall by Using NLP in Your Stakeholder Workflows

This session explores the potential failed promise of intelligence dashboards and how the delivery objective should center on the stakeholder workflow, rather than the resource itself. If you’ve just created an internal CI dashboard, are struggling with changing stakeholder behavior, or are considering a budget for dashboard creation, don’t miss this session.

Presented by FENIX and CSL Seqirus

Refresh & Connect in Exhibition Hall

Leveraging Digital Tools For Conference Coverage: ASCO 2022 case study

• Challenges faced by pharma teams with respect to conference preparation and coverage

• Information management from public domain: sifting through the ‘noise’
• Using the hybrid of technology and human touch to create successful outcomes
• Case study: ASCO2022

Presented by Larvol

An Interactive Session Exploring the Main Trends in the Life Science & Healthcare Industry and How CI can Support Organisations Staying Ahead of the Curve

Presented by Deallus

Future Impact of AI and ML in the Pharma Industry

Presented by GlaxoSmithKline

Networking Luncheon

“Ask the Experts” Interactive Roundtables

(Explore and capture the power of participants’ insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
ROUNDTABLE 1
CI Organizational Setup- the Pros and Cons of Different Company Approaches

Presented by Novartis

ROUNDTABLE 2
Insights for New Product and Business Development in a Biotech Startup

Presented by Alentis Therapeutics

ROUNDTABLE 3
The Role and Position of BI within Project Teams – Expectations vs Reality

• How and to which level is BI is involved in project team activities (regular ones and/or strategic ones)

• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)

Presented by SOTIO, a.s.

ROUNDTABLE 4
Global to Local Forecasting

Presented by Bristol Myers Squibb and Menarini

Enterprise Intelligence: A Lone Wolf Activity, or a Corporate Capability?

Presented by Novartis

But How Do You Feel? Using Neuromarketing Techniques to Understand Unconscious Emotions in Medical Decision Making and Communication

Medical decision making is often driven by unconscious emotional responses, yet traditional marketing techniques often fail to tap into these underlying drivers. Consumer Neuroscience techniques, such as fMRI-based analyses, provide a unique opportunity to gain insights into the emotional components of medical decision making, both for physicians and patients.

In this talk, we will explore the use of neuromarketing techniques in the medical industry and how they can help us understand the unconscious emotions that influence medical decision making. We will present a series of case studies that reveal the emotional components driving medical decision making, and explore how this knowledge can be used to improve marketing strategies and communication in the medical industry.

Moreover, we will discuss the challenges of implementing neuromarketing techniques in the medical industry, including ethical considerations and the need for specialized training. However, the potential benefits of using these techniques to understand the unconscious emotions of patients and physicians far outweigh these challenges.

By the end of this talk, attendees will have a greater understanding of how neuromarketing techniques can be used to understand unconscious emotions in medical decision making. They will also gain insights into how to develop more effective marketing strategies and communication that appeal to the emotional and intuitive responses of both physicians and patients, ultimately leading to more successful engagement and increased sales.

Overall, this talk will provide valuable insights into the power of neuromarketing techniques to improve marketing and communication in the medical industry, and how understanding the unconscious emotions of patients and physicians is key to success in this field.

Presented by University of Amsterdam

Closing Remarks from Co-Chairs

Presented by Novartis and STADA

Conference Concludes